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Intracellular adenosine 3',5'-phosphate formation is essential for down-
regulation of surface adenosine 3',5'-phosphate receptors in Dictyostelium
Peter J. M. VAN HAASTERT
Department of Biochemistry, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands
Dictyostelium discoideum cells contain cell surface cyclic AMP
(cAMP) receptors that bind cAMP as a first messenger and
intracellular cAMP receptors that bind cAMP as a second
messenger. Prolonged incubation of Dictyostelium cells with
cAMP induces a sequential process of phosphorylation, seques-
tration and down-regulation of the surface receptors. The role of
intracellular cAMP in down-regulation of surface receptors was
investigated. Down-regulation of receptors does not occur under
conditions that specifically inhibit the formation of intracellular
cAMP (the drug caffeine or mutant cells lacking adenylate
cyclase) or conditions that inhibit the function of intracellular
cAMP (mutants lacking protein kinase A activity). Cell-
permeable non-hydrolysable cAMP derivatives were used to
INTRODUCTION
Cyclic AMP (cAMP) plays an important role in different signal-
transduction pathways in Dictyostelium discoideum. On starv-
ation, a group of cells starts to secrete cAMP which is recognized
by surrounding cells. The cells move towards the centre of the
cAMP secretion. Eventually, all the cells that join the aggregate
develop into a multicellular structure, the fruiting body. This
fruiting body consists of viable spore cells on top of a stalk of
dead cells [see Loomis (1985)].
Dictyostelium cells have several receptors that interact with
cAMP: cell surface receptors (cARs) to detect extracellular cAMP
as a first messenger, intracellular cAMP-dependent protein kinase
(PKA) to detect intracellular cAMP as a second messenger, and
extracellular and intracellular cyclic nucleotide phosphodiester-
ase to degrade cAMP (see Van Haastert et al., 1991). The genes
encoding these proteins have been identified (Lacombe et al.,
1986; Mutzel et al., 1987; Klein et al., 1988; Saxe et al., 1991).
The derived amino acid sequences of cARs predict proteins with
seven putative spanning segments and a cytosolic C-terminal
domain, indicative of G-protein-coupled receptors (Klein et al.,
1988). The deduced structure of the regulatory subunit of PKA
is very different from that of cARs; it shows strong homology
with mammalian regulatory subunits of PKA (Mutzel et al.,
1987). Using analogues of cAMP it has been shown that these
receptors possess very different cyclic nucleotide-binding specifi-
cities (De Wit et al., 1982; Van Haastert and Kien, 1983; Van
Ments-Cohen and Van Haastert, 1989). Cyclic nucleotide deriva-
tives that bind specifically to cARs or to intracellular PKA have
been used to demonstrate the role of each of the receptors (Van
Haastert and Kien, 1983; Van Haastert, 1983; Schaap and Van
Driel, 1985; Theibert et al., 1986; Haribabu and Dottin, 1986;
Oyama and Blumberg, 1986; Kimmel, 1987; Mann and Firtel,
1987).
investigate further the requirement of intracellular cAMP for
down-regulation. The Sp isomer of 6-thioethylpurineriboside
3',5'-phosphorothioate (6SEth-cPuMPS) does not bind to the
surface receptor, enters the cell and has relative high affinity for
protein kinase A. 6SEth-cPuMPS alone has no effect on down-
regulation. However, together with an agonist of the surface
receptor, the analogue induces down-regulation in caffeine-
treated wild-type cells and in mutant cells lacking adenylate
cyclase, but not in mutant cells lacking protein kinase A. These
results indicate that intracellular cAMP formation and activation
of protein kinase A are essential for down-regulation of the
surface cAMP receptor.
Duriug aggregation, extracellular cAMP activates multiple
second-messenger enzymes, such as adenylate cyclase, guanylate
cyclase and phospholipase C (see Van Haastert et al., 1991). The
second messengers co-ordinate at least two cellular responses,
chemotaxis and induction of postaggregative gene expression
(see Schaap, 1986). Besides induction of second messengers and
physiological responses, prolonged activation of the receptor
also leads to desensitization of sensory transduction (Devreotes
and Steck, 1977; Klein and Juliani, 1977; Van Haastert and Van
der Heijden, 1983). Many components are known to contribute
to desensitization at the level of cARl (Klein and Juliani, 1977;
Klein et al., 1985, 1987; Theibert and Devreotes, 1986; Van
Haastert et al., 1992): (i) phosphorylation of cARl, which has
been suggested to inhibit receptor-G-protein interaction; (ii)
functional sequestration of the cARl protein to a state in which
it no longer binds cAMP (called loss of ligand binding); (iii)
physical sequestration of the cARl protein into patches; (iv)
degradation of the receptor (called down-regulation); (v) finally,
rapid degradation of cARl mRNA. A detailed genetic and
pharmacological study has revealed that each of these com-
ponents requires partly overlapping but distinct second-
messenger responses (Van Haastert et al., 1992). The role of
intracellular cAMP in desensitization was investigated using
caffeine and the mutant synag 7, situations in which receptor-
stimulated adenylate cyclase is inhibited (Brenner and Thoms,
1984; Theibert and Devreotes, 1983; Schaap et al., 1986). These
experiments revealed that activation of adenylate cyclase is not
required for receptor phosphorylation, loss of ligand binding and
loss of cARl mRNA. However, the final degradation of the
cARl protein does not occur when activation of adenylate
cyclase is prevented (Van Haastert et al., 1992).
Another approach to the study of the function of intracellular
cAMP is to use cAMP derivatives that bypass the surface
receptor and directly activate the intracellular receptor. In
Abbreviations used: cAR, cell surface cAMP receptor; PKA, cAMP-dependent protein kinase; cAMP, adenosine 3',5'-phosphate; cAMPS, adenosine
3',5'-phosphorothioate; 6SEth-cPuMPS, 6-thioethylpurineriboside 3',5'-phosphorothioate; dcAMPS, 2'-deoxyadenosine 3',5'-phosphorothioate. All
cAMPS derivatives have the Sp conformation, unless indicated otherwise.
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Dictyostelium these cAMP derivatives require the following
properties: (1) resistance to hydrolysis by phosphodiesterase to
prevent side effects of metabolites; (2) cell-permeability; (3) high
affinity for PKA and low affinity for cARs. Previous studies on
the activity of cAMP derivatives (De Wit et al., 1982; Van
Haastert and Kien, 1983) were used to select putative candidates
from a series of new cAMP analogues designed to activate
mammalian PKA (Genieser et al., 1988; Dostman et al., 1990).
Modifications in the adenine moiety provide selectivity for
PKA. Lipophilic substitutions were chosen to increase cell
permeability. Finally, replacement of an exocyclic oxygen by
sulphur dramatically reduces hydrolysis by phosphodiesterase
(Rossier et al., 1978; Van Haastert et al., 1983; Eckstein, 1985;
Braumann et al., 1986), but also introduces an asymmetric
phosphorus atom. The Sp isomer of adenosine 3',5'-phos-
phorothioate (cAMPS) is an agonist ofPKA in mammalian and
Dictyostelium cells, whereas the Rp isomer is an antagonist of
mammalian PKA (Rothermel et al., 1983) but, unfortunately,
not of Dictyostelium PKA (De Wit et al., 1984). The analogue
that best meets the criteria for a selective cell-permeable non-
hydrolysable PKA agonist is the (Sp) isomer of 6-thioethyl-
purineriboside 3'5'-monophosphorothioate (6-SEth-cPuMPS)
(Schaap et al., 1993).
Mutants were recently made that either cannot make in-
tracellular cAMP because of inactivation of the adenylate cyclase
gene (Pitt et al., 1992) or cannot respond to intracellular cAMP
as a result of inactivation of the catalytic subunit ofPKA (Mann
et al., 1992). In the present study, down-regulation of surface
receptors is analysed in these mutants, demonstrating that both
cell lines lack cAMP-induced degradation of the receptor protein.
The cell-permeable analogue that bypasses the surface receptor
and directly activates intracellular PKA is shown to overcome
the inhibition ofcAMP-mediated down-regulation in cells lacking
adenylate cyclase, but not in cells lacking PKA activity.
EXPERIMENTAL
Materials
[8-3H]cAMP (1.92 TBq/mmol) was obtained from Amersham
Corp. (Amersham, Bucks., U.K.). cAMP was obtained from
Boehringer (Mannheim, Germany). Dithiothreitol and (Sp)-
cAMPS were from Sigma. cAMP analogues were obtained from
Biolog (Bremen, Germany) and kindly provided by Dr. Jastorff
and Dr. Genieser; their synthesis has been described previously
(Genieser et al., 1988).
Conditions for growth and development
D. discoideum mutant cells synag 7 (strain N7) were grown in
association with Escherichia coli 281 on a solid medium con-
taining 3.3 g of peptone, 3.3 g of glucose, 4.5 g of KH2PO4, 1.5 g
of Na2HPO4,2H20 and 15 g of agar/litre. Wild-type cells (strain
AX3) and mutant cells aca- and pk3- were grown in liquid HG5
medium containing 14.3 g of peptone, 10 g of glucose, 7.15 g of
yeast extract, 0.49 g of KH2PO4 and 1.36 g of Na2HPO4,2H20
per litre. Control transformants aca-IACG and pk3-/PK3 were
grown in HG5 medium supplemented with 10 #g/ml G418. Cells
were harvested, washed and resuspended in 10 mM sodium/
potassium phosphate buffer, pH 6.5 (PB buffer).
Loss of ligand binding and down-regulation of surface receptors,
analysed by Scatchard plots
Cells were starved in suspension for 5 h; mutant cells synag 7,
aca-, aca-/ACG and pk3- were pulsed with 0.1 uM cAMP at
5 min intervals. Cells were washed, resuspended in PB buffer,
and incubated at a density of 107 cells/ml in the absence or
presence of 300 ,uM cAMP for 15 min or 1.5 h.
To assess loss of ligand binding of the receptor, cells were
incubated with cAMP for 15 min at 22 'C. They were subse-
quently collected by centrifugation at 4 'C for 2 min at 700 g,
washed twice by centrifugation with ice-cold PB buffer, and
resuspended in ice-cold PB buffer. cAMP binding to exposed
cARs was measured in a total volume of 100 pl of PB buffer
containing different concentrations of [3H]cAMP, 10 mM dithio-
threitol and 80,l of the cell suspension (I07 cells, unless stated
otherwise). The incubation at 0 'C was terminated after 1 min by
centrifugation for 2 min at 14000 g and the supernatant was
aspirated.
To assess down-regulation of the receptors, cells were incu-
bated with cAMP for 1.5 h at 22 'C. They were subsequently
collected, washed and resuspended in PB buffer as described
above. Unless stated otherwise, the suspension was incubated for
20 min at 22 'C, and then placed on ice. cAMP binding to all
residual cARs was measured in a total volume of 1 ml of PB
buffer containing 78 % satd. (NH4)2SO4, different concentrations
of [3H]cAMP, 1 mM dithiothreitol, 50 ,ug of BSA and 80 ,u of
cell suspension. The incubation at 0 'C was terminated after
5 min by centrifugation for 2 min at 14000 g and the supernatant
was aspirated.
The pellets from both assays were dissolved in 100 Iul of 0.1 M
acetic acid, 1.3 ml of Scintillator (Packard 299) was added and
radioactivity was determined. Non-specific binding was measured
in the presence of 0.1 mM cAMP. To demonstrate that cAMP
was effectively removed during the washing procedure, cells were
incubated on ice with cAMP for less than 3 s and washed
immediately. Binding of cAMP in phosphate buffer and in
(NH4)2SO4 to these cells was compared with binding to cells that
were not briefly incubated with cAMP; there was no significant
difference in the binding data (Van Haastert, 1987).
Binding curves were fitted to a model ofone or two independent
binding sites by non-linear least-squares analysis using the
program Pfit. The following equation for two independent
binding sites was used (Thakur et al., 1972):
B/F = 0.5 ((B1-B)/K1 + (B2-B)/K2 + ([(B1-B)/K1
- (B2 -B)/K2]2 + 4K1K2B(B-B1j-B2)1 5)
where Bi and B2 are the maximal binding for binding sites 1 and
2 respectively and K1 and K2 are their dissociation constants.
Model discrimination between one and two binding sites was
made by calculating:
F N-P2 SS1-SS2F= X
P2-P1 SS2
where N is the number of data points, p is the number of free
parameters and SS is the residual sum of squares; subscripts 1
and 2 denote the smaller and larger model respectively. The
degrees of freedom ofF are (P1-P2, N-P2). In all cases the two-
site model fitted the data significantly better (at P < 0.01) than
the one-site model; for aca-/ACG cells (Figure 2b) the two-site
model was preferred at P < 0.05.
Down-regulation of surface receptors induced by cAMP analogues
Insufficient quantities of the cAMPS analogues prevent analysis
of their effects on cAMP receptors using complete Scatchard
plots. Cells were starved as described above. The miniature
incubations contained 5 mM caffeine, 300,uM cAMP and/or
100 uM cAMPS derivatives and 0.75 x 107 cells in a total volume
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Figure 1 Scatchard analysis of cAMP binding in Dictyostelium cells
Wild-type cells were incubated with 0.3 mM cAMP for 15 min (a and c) or 1.5 h (b and d). Cells were washed extensively and resuspended at 0 OC. cAMP binding was measured immediately
to control cells (0) and cAMP-treated cells (-), or after an additional 20 min incubation at 22 OC to cAMP-treated cells (V). The binding assays were performed in phosphate buffer (total
volume 100 ,I; a and b) or in nearly saturated (NH4)2SO4 (total volume 1 ml; c and d). The incubation mixtures contained 2 x 107 cells. The results shown are means of triplicate determinations
from an experiment performed twice. See Table 1 for statistical analysis of the binding curves.
of 250 ,tl. The incubation times and washing procedures were as
described above, except that smaller volumes were used. Finally,
cells were resuspended in 400,u of PB buffer, incubated for
20 min at 22 °C, and assayed for cAMP binding in (NH4)2SO4
using 10 nM [3H]cAMP.
RESULTS
Optimal assay conditions for loss of ligand binding and down-
regulation
Dictyostelium cells possess a heterogeneous population of surface
cAMP-binding sites. In phosphate buffer, exposed binding sites
are detected. When the binding assay is performed in nearly
saturated (NH4)2S04, the sites have a 15-20-fold higher affinity.
Scatchard analysis ofcAMP binding in phosphate buffer reveals
two binding forms with high (60 nM) and low (750 nM) affinity
(Figure la; see Table 1 for analysis ofScatchard plots). Treatment
of these cells with cAMP for 15 min leads to a large decrease in
exposed binding sites of both the high- and low-affinity class;
their affinities are not changed significantly (Figure la and Table
1). Apparently cAMP induces the loss of exposed binding sites.
These binding sites are not degraded, as they are still detectable
in (NH4)2S04 (Figure lc and Table 1), but they have an
approximately 3-fold reduced affinity compared with control
binding in (NH4)2SO4. When cells treated with cAMP for 15 min
are incubated without cAMP for 20 min, binding in phosphate
buffer is partly restored (Figure la), whereas the reduction in
affinity in (NH4)2S04 is completely reversed (Figure ic).
Treatment of cells for 1.5 h with cAMP leads to a large
decrease in binding sites detected in phosphate buffer, which only
partly recovers on removal of cAMP (Figure lb). When these
cells are assayed for cAMP binding in (NH4)2SO4, a 2-fold
reduction in affinity is observed and a 5000 decrease in the
number of binding sites. This reduction in affinity is restored
within 20 min on removal of cAMP, but the loss of binding sites
is persistent (Figure ld). These results suggest that a short
(15 min) incubation of cells with cAMP leads to loss of about
80% of exposed binding sites. These sites are still detectable in
(NH4)2SO4, but have a reduced affinity, which disappears within
20 min of removal of cAMP. A long (1.5 h) incubation of cells
with cAMP also leads to loss of cAMP binding in (NH4)2SO4.
Previous experiments have shown that the loss of binding in
(NH4)2SO4 is correlated with the loss of receptor protein as
detected on Western blots (Van Haastert et al., 1992). Thus loss
of ligand binding is detected in phosphate buffer after treatment
of cells with cAMP for 15 min, whereas down-regulation of the
receptor is detected in (NH4)2S04 after treatment of the cells with
cAMP for 1.5 h followed by a 20 min incubation of these cells
without cAMP to restore the reduced affinity of the remaining
receptors.
Inhibition of intracellular cAMP formation inhibits down-regulation
Caffeine is a relatively specific inhibitor of receptor-mediated
activation of adenylate cyclase in Dictyostelium. This compound
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Table 1 Analysis of binding curves
Data from the Scatchard plot were fitted for cAMP binding to one or two independent binding sites as described in the Experimental section; in all cases the two-binding site model was preferred.
The results shown are the means and 95% confidence limits. The incubation mixtures contained 2 x 107 cells for AX3 and pk3 and 107 cells for the other strains. For calculation of the number
of binding- sites per cell, note that the volume of the assay was 1 ml, except for binding in PB buffer, which was 100 utl.
Site 1 Site 2 B;tal





cAMP 15 min, buffer 20 min
cAMP 1.5 h




cAMP 15 min, buffer 20 min
cAMP 1.5 h































































5.1 + 0.4 0.97 + 0.05
7.0+0.7 0.92+0.06
3.4+0.3 1.49+0.08
3.3 + 0.4 0.70 + 0.05
2.7+0.3 0.51 + 0.03



























2.9+0.5 0.53+0.04 2.96+0.18 100
2.8 + 0.8 0.25 + 0.04 1.45 + 0.16 48.8 + 6.2
effect on loss of ligand binding (Van Haastert et al., 1992; see
also Table 2).
Recently the gene encoding the aggregation-stage-specific
adenylate cyclase (ACA) has been cloned and a cell line generated
in which the gene was inactivated [aca- cells (Pitt et al., 1992)].
Mutant aca- cells have relatively normal levels ofcARs, provided
that the cells are pulsed with cAMP during starvation. A short
incubation of these cells with cAMP results in 76 + 7 %/' loss of
exposed binding sites, which is not significantly different from
control cells (Scatchard plots not shown). In contrast, prolonged
incubation of aca- cells with elevated cAMP concentrations does
not lead to a significant down-regulation of the surface cAMP
receptor (Table 1 and Figure 2a). A second adenylate cyclase
gene has been identified, ACG, that is expressed specifically in
spores (Pitt et al., 1992). This gene has been introduced into the
aca- cells under the control of the actin-15 promoter which is
active during growth and aggregation resulting in cells with high
constitutive adenylate cyclase activity (aca-IACG cells; Pitt et
al., 1992). These aca-/ACG cells were incubated for a short and
long period with cAMP, and exposed and total binding sites were
measured in phosphate buffer and (NH4)2SO4 respectively. The
results demonstrate that cAMP induces essentially normal loss of
ligand binding (Scatchard plots not shown) and down-regulation
of cAMP receptors (Table 1 and Figure 2b) in aca-IACG cells
compared with wild-type cells. It should be mentioned that both
aca- and aca-IACG cells have a much larger fraction of high-
affinity binding sites than wild-type cells. The precise nature of
high- and low-affinity binding forms is not known for wild-type
Dictyostelium cells in vivo, although it has been shown that the
different receptor gene products have different affinities, and
GTP changes the affinity of cARl in membranes.
The gene encoding the catalytic subunit of PKA has been
identified in Dictyostelium (Burki et al., 1991; Mann and Firtel,
1991). A pk3- cell line was constructed, in which this gene was
inactivated by homologous recombination (Mann et al., 1992).
These cells have a consistently 2-4-fold reduced level of cAMP-
binding sites compared with control cells. cAMP induces the
normal loss of exposed binding sites during a 15 min incubation
(Scatchard plot not shown), but it does not induce down-
regulation of the cAR in these cells (Table 1 and Figure 3a).
Statistical analysis of the Scatchard plots reveals that cAMP
treatment of pk3- cells leads to a shift of high- to low-affinity
binding sites and to a reduction in their affinities, but not to a
reduction in the total number of binding sites (see Table 1).
Down-regulation was determined in a control cell line in which
PK3 was reintroduced into the pk3- strain under the control of
an actin promoter (pk3-/PK3 cells); down-regulation of surface
receptors was restored to control values (Table 1 and Figure 3b).
Cell-permeable PKA agonist and down-regulation of surface
receptors
Recently analogues of cAMP have been identified that are cell-
permeable, resistant to hydrolysis by phosphodiesterase, have
high affinity for intracellular PKA and do not bind to the cAR
of Dictyostelium (Schaap et al., 1993). The most potent analogue
is 6SEth-cPuMPS; the analogue dcAMPS is used as a control as
this compound has a similar polarity to 6SEth-cPuMPS but
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Figure 2 Scatchard plot of cAMP binding to surface receptors In cells
lacking adenylate cyclase (a; aca-) and aca- cells expressing a different
adenylate cyclase (b; aca-/ACG)
Cells were starved for 5 h in the presence of cAMP pulses, washed and incubated in the
absence (0) or presence (0) of 0.3 mM cAMP for 1.5 h. After extensive washing of the cells,
cAMP binding to 107 cells was measured in nearly saturated (NH4)2S04. The arrows indicate
the cAMP concentration used in the experiment presented in Table 2. The results shown are
means of triplicate determinations from three (a) or two (b) independent experiments. See Table
1 for statistical analysis of the binding curves.
cannot activate PKA. The experiments presented in Table 2
investigated whether these analogues can restore down-regulation
under conditions in which synthesis or detection of intracellular
cAMP is absent. Owing to the limited availability of the
analogues, the subsequent binding reactions were performed not
by Scatchard analysis but at one relatively high [3H]cAMP
concentration.
In wild-type AX3 cells, 6SEth-cPuMPS alone does not induce
down-regulation, and also does not interfere with cAMP-induced
down-regulation (Table 2). In the presence of caffeine, 6SEth-
cPuMPS together with cAMP induces substantial down-regul-
ation of the surface receptor. 6SEth-cPuMPS cannot be replaced
in this response by dcAMPS, a surface-selective agonist. A
dose-response curve of 6SEth-cPuMPS-contributed down-
regulation reveals a half-maximal effect at about 30 ,uM 6SEth-
cPuMPS (Table 2).
The analogue 6SEth-cPuMPS partly restores cAMP-induced
down-regulation in the mutant synag 7, which shows a defect in
the activation of adenylate cyclase, and in the mutant aca-,
which has no adenylate cyclase activity. The analogue cannot
restore down-regulation in mutant pk3-, which is defective in
PKA (Table 2).
Summarizing, the experiments demonstrate that down-regul-
ation of cARs does not occur under conditions that specifically
Figure 3 Scatchard plot of cAMP binding to surface receptors in cells
lacking the catalytic subunit of PKA (a; pk3) and pk3 cells expressing
PK3 from the actin promoter (b; pk3/PK3)
Cells were starved for 5 h in the presence of cAMP pulses, washed and incubated in the
absence (0) or presence (0) of 0.3 mM cAMP for 1.5 h. After extensive washirg of the cells,
cAMP binding was measured in nearly saturated (NH4)2S04. The binding assay contained
2 x 107 and 107 cells in (a) and (b) respectively. The arrows indicate the cAMP concentration
used in the experiment presented in Table 2. The results shown are means of triplicate
determinations from three independent experiments. See Table 1 for statistical analysis of the
binding curves.
Table 2 Recovery of down-regulation by cell-permeable PKA agonist
Wild-type AX3 and mutant cells were incubated in the absence or presence of 0.3 mM cAMP,
5 mM caffeine or 6SEth-cPuMPS for 1.5 h. Cells were extensively washed, and binding of
10 nM [3H]cAMP to cell surface receptors was determined in (NH4)2S04 (for mutant pk3
50 nM [3H]cAMP was used to circumvent the change in affinity forms induced by cAMP; see
Figure 3a). The results are presented as percentage down-regulation, i.e. the decrease in cAMP
binding relative to cells incubated without cAMP. The data shown are means+S.D. of two
experiments carried out in triplicate.
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Figure 4 Role of intracellular cAMP in down-regulation of cAR
Binding of cAMP to cARs leads to their activation (cAR1*), phosphorylation (cAR1P), loss of ligand binding (cARl^) and degradation (cARid). Conditions and mutants that inhibit specific signal-
transduction components are boxed. The analogue 6SEth-cPuMPS does not bind to the cAR but can pass through the plasma membrane and activate PKA directly. Besides activation of adenylate
cyclase and PKA, the results suggest additional requirements for down-regulation.
inhibit the formation (caffeine, aca-) or function (pk3-) of
intracellular cAMP. A cell-permeable cAMP analogue restores
down-regulation when cAMP synthesis is defective, but not in
PKA mutants with defective intracellular cAMP function.
DISCUSSION
Down-regulation of cARs is the final irreversible step in a
complex desensitization process. The kinetics of these desensi-
tization reactions as well as mutational analysis (Van Haastert et
al., 1992) suggest a scheme as summarized in Figure 4. Binding
of cAMP to receptor cARl leads to its activation, cARl *. The
activated receptor interacts with G-proteins, leading to stimu-
lation of adenylate cyclase, guanylate cyclase and phospholipase
C. Within a few minutes cAMP also induces phosphorylation of
the receptor, cARIP, presumably leading to uncoupling of the
receptor from the G-protein. Studies with mutant fgd A reveal
that activation of these second messengers is not required for
receptor phosphorylation. On a similar time scale as phosphoryl-
ation, the receptor becomes functionally sequestered such that it
no longer binds cAMP (loss of ligand binding, cARl^). Loss of
ligand binding is induced by the analogue (Rp)-cAMPS, which
does not induce activation or phosphorylation of the receptor.
Finally, after 1 h of stimulation the receptor becomes undetect-
able and is degraded (down-regulation, cARId).
In this study the role of intracellular cAMP in loss of ligand
binding and down-regulation of the receptor was studied in
detail. The optimum protocol for measuring loss of ligand
binding is incubation of cells for 15 min with cAMP followed by
removal of cAMP and detection of surface cAMP-binding
activity in phosphate buffer. The results show that about 750 of
the receptors have lost their binding activity after this treatment.
Intracellular cAMP appears not to play an important role in this
process, as loss of ligand binding is essentially normal in mutant
cells that lack adenylate cyclase or the catalytic subunit of PKA.
The receptors that do not bind cAMP in phosphate buffer still
bind cAMP in nearly saturated (NH4)2SO4 (Van Haastert, 1985).
Thus receptors are not degraded after 15 min of incubation with
cAMP. These receptors, however, have changed their affinity for
cAMP (Figure 1c). This change in affinity is reversible on
removal ofcAMP with a half-time of several minutes (Figure 1).
As mentioned above, incubation of cells with cAMP for 15 min
leads to phosphorylation of the receptor and loss of ligand
binding in phosphate buffer. The following experiments suggest
that the reduced affinity in (NH4)2SO4 is related to phosphoryl-
ation of the receptor rather than loss of ligand binding.
The analogue (Rp)-cAMPS induces loss of ligand binding but
not the phosphorylation of the receptor; cells treated with
(Rp)-cAMPS have receptors with a normal binding affinity in
(NH4)2SO4 (Van Haastert et al., 1992). Secondly, the affinity of
the receptor is restored to control values after a 20 min incubation
at 22 °C (Figure 1); dephosphorylation of cARl occurs with
similar characteristics (Klein et al., 1987), whereas loss of ligand
binding reverts much more slowly at 22 °C (Van Haastert, 1987).
The decrease in binding affinity hinders the rapid detection of the
number of binding sites, as complete Scatchard analysis should
be carried out for each experiment. The affinity of the receptor is
restored relatively rapidly at 22 °C (20 min), whereas de novo
synthesis of the receptor is slow [several hours (Van Haastert et
al., 1992)]. Therefore the optimum protocol for measuring down-
regulation is incubation ofthe cells with cAMP for 1.5 h, removal
of cAMP and subsequent incubation for 20 min at 22 °C,
followed by the binding assay in (NH4)2SO4. With this protocol,
cAMP induces about 500% down-regulation of cARs. Intra-
cellular cAMP appears to play an essential role in this process.
Previous experiments with the drug caffeine and the mutant
Down-regulation of cyclic AMP receptors in Dictyostelium 545
synag 7 suggested that down-regulation may require receptor-
mediated activation of adenylate cyclase (Van Haastert et al.,
1992). In the present report down-regulation of surface cAMP
receptors was investigated using a combination of specific
mutants defective in adenylate cyclase (Pitt et al., 1992) and the
catalytic subunit ofPKA (Mann et al., 1992) with non-hydrolys-
able cAMP derivatives designed to activate intracellular PKA in
Dictyostelium (Schaap et al., 1993). 6SEth-cPuMPS was selected
from a large group of analogues (Genieser et al., 1988) because
it is lipophilic, has high affinity for PKA and low affinity for
surface receptors. The derivative reaches an intracellular con-
centration that is sufficient to activate intracellular PKA at an
applied extracellular concentration that does not activate surface
receptors. The present results demonstrate that cAMP does not
induce down-regulation in caffeine-treated wild-type cells, in
mutant aca- lacking adenylate cyclase or in mutant pk3- lacking
the catalytic subunit of PKA. Down-regulation in these mutant
cells is restored by expressing, under the control of an actin
promoter, another adenylate cyclase gene (aca-/ACG) or PK3
respectively. The cell-permeable PKA agonist together with
cAMP restores down-regulation of the surface receptor in wild-
type cells treated with caffeine or in aca- cells, but not in pk3-
cells. These results imply that intracellular cAMP accumulation
and activation of PKA are essential for down-regulation of
surface receptors.
Although intracellular cAMP is essential for down-regulation
of cARs, the present study indicates that this is not sufficient. The
cell-permeable PKA agonist alone does not induce down-regu-
lation, but must be added in combination with extracellular
cAMP, suggesting two requirements for down-regulation: ac-
tivation of adenylate cyclase and activation or modification of
cAR. Two hypotheses could provide an explanation for these
observations. Down-regulation may only occur after the receptor
has been modified by either ligand-dependent phosphorylation
or loss of ligand binding. As the PKA agonist does not bind to
the surface receptor, it does not provide this requirement. The
second hypothesis proposes the requirement of other second-
messenger responses besides adenylate cyclase activation for
down-regulation, i.e. activation of phospholipase C or guanylate
cyclase. Additional experiments with mutants lacking other
signal-transduction pathways are required to distinguish between
these models.
The receptorcAR l remains down-regulated as long as extracell-
ular cAMP is present. The question then arises which receptor
detects cAMP and how are the second-messenger systems acti-
vated in down-regulated cells? Detailed studies on the regulation
of adenylate cyclase in mutant cells indicate that cARl is not
essential for activation of this enzyme (Puppilo et al., 1992). Thus
another surface receptor may transduce the signal to adenylate
cyclase to keep cARl in the down-regulated state.
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